FibroBiologics, Inc. held a Special Meeting on February 20, 2026, where stockholders approved several proposals, including a reverse stock split ranging from 1-for-5 to 1-for-30 and the issuance of up to 12,110,203 shares from outstanding common warrants. A total of 54,974,113 votes were cast with significant support for these changes.